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Background: Although different techniques for sperm immobilization have been described, their value has not
been assessed in an adequately powered randomized study. The aim of this study was to compare two types of
sperm immobilization methods prior to ICSI and to test the hypothesis that triple touch immobilization (TTIm)
would lead to a higher (5% -65% up to 70%) fertilization rate (FR) than single touch immobilization (STIm).
Methods: A total of 3056 metaphase II (MII) oocytes, from 290 patients, were randomly assigned to the STIm group
(n = 1528 oocytes; 145 cycles) or to the TTIm group (n = 1528 oocytes; 138 cycles). A total of 1478 oocytes (STIm
group) and 1476 oocytes (TTIm group) were used in the statistical analysis. The primary outcome variable was FR.
Secondary outcome variables included: number of good quality embryos (GQE) on day 2 and day 3, implantation
rate (IR) and implantation with foetal heart beat rate (FHB). Statistical analysis was done using the Fisher Exact test
with a significance level of 0.05.
Results: The results showed no differences in FR between both groups. The proportion of good quality embryos
on day 3, was significantly higher in the STIm group (37.5%) compared to the TTIm group (31.8%; p = 0.02).
Conclusions: In this RCT, the hypothesis that the post-ICSI FR would be higher after TTIm than after STIm was not
confirmed and the number of good quality embryos on day 3 was significantly lower in the TTIm group than in
the STIm group. These data suggest that more ‘aggressive’ TTIm technique has no advantages compared to the
STIm technique.
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Sperm plasma membrane damage has been described as
a necessary process prior to intracytoplasmic sperm in-
jection (ICSI) [1-4], as it plays a key role in the oocyte
activation caused by the spermatozoon [3,4]. However, it
is not fully understood to which extent sperm plasma
membrane damage [3] is needed for adequate oocyte acti-
vation in the context of Assisted Reproductive Technology
(ART) treatments.
Since the introduction of ICSI a number of studies have
been conducted to evaluate the immobilization of sperm-
atozoa prior to ICSI as a method to induce sperm plasma
membrane damage before ICSI. Immobilization induces* Correspondence: goedele.paternot@uzleuven.be
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reproduction in any medium, provided the orpermeabilization of the sperm membrane and enhances
subsequent nuclear decondensation [3]. Although the use
of motile sperm cells instead of immobilized sperm has
been promoted in the past [5], most studies agree that the
use of immobilized sperm is necessary to provoke the pro-
cesses needed prior to fertilization [1-4,6].
Different immobilization techniques can be used to in-
duce sperm membrane permeabilization. The conven-
tional method for immobilization consists of compressing
the tail of the spermatozoon against the bottom of a dish
with a micro injection pipette until a clear bend is visible
[4]. More aggressive mechanical techniques include: per-
manently crimping the tail in the mid-piece region [4],
cutting the tail below the mid-piece region [7], cutting
halfway between the head and the tip of the tail [1] and
dissecting the tail at the tip [8]. Finally, the application ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Patients’ and cycles characteristics of the study
objects
Patient characteristics
Mean Age Female (±SD) 31.68 (±4.47)
Mean Age Male (±SD) 34.58 (±5.96)
Cause of subfertility
N Tubal factor (%) 53 (11)
N Ovulation (%) 68 (15)
N Endometriosis (%) 51 (11)
N Implantation (%) 14 (3)
N Other (%) 13 (3)
N No female indication (%) 260 (57)
N Male factor (%) 398 (87)
Total Motility Count (Median/Min/Max)(x 106) 4.28 (2.00/< 0.01/40.50)
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sperm immobilization prior to ICSI.
When compared to the standard method, higher post
ICSI fertilization rates for ejaculated spermatozoa have
been reported after more aggressive mechanical [1,2,4,7]
or piezo-pulse induced [12] sperm immobilization, but
not after cutting the tail of the spermatozoon at different
places [6] or applying laser-induced (non-contact 1.48-
μm diode laser) sperm immobilization [10,11] techni-
ques for sperm immobilization.
Although different techniques for sperm immobilization
before ICSI have been described, their value has not been
assessed in an adequately powered randomized study. The
majority of studies mentioned above were published more
than 10 years ago in selected groups, i.e. men with
oligoterato- or oligoasthenozoospermia [1,7] and using a
low number of oocytes (about 500 oocytes) except for 1
study (6419 oocytes) [4]. No subsequent study has been
conducted recently, including a large number of oocytes
in a patient population representative for routine clinical
practice. As biological plausibility [3] and observational lit-
erature data support the possibility that more sperm
plasma membrane damage may lead to higher fertilization
rate after ICSI, the aim of our study was to test the
hypothesis that triple touch sperm immobilization
(TTIm) would lead to a higher fertilization rate (FR)
after ICSI than single touch sperm immobilization
(STIm). The hypothesis is that the damage induced to
the mid-piece region would imply a more successful
outcome in ICSI, due to the fact that the mitochon-
dria are tightly packed and located only in the mid-
piece region [13].Methods
Patients
All ART ICSI cycles between April 2009 and January
2010 were eligible for our randomized study, except ICSI
cycles combined with pre-implantation genetic diagnosis
(PGD), or ICSI cycles using either immotile sperm from
fresh ejaculate, or sperm from testicular biopsies. Patients
received treatment with ICSI mostly for the indication of
severe male factor infertility (87%) (See Table 1). The ovar-
ian stimulation and egg retrieval protocols have been
described in detail before [14].Semen collection and preparation
Briefly, semen samples were processed following the SOPs
(Standard Operating Procedures) of the Leuven University
Fertility Centre (LUFC).
Semen samples were collected by masturbation and pre-
pared after liquefaction (20 minutes at 37°C) [15,16]. The
samples were prepared on a three layer Isolate gradi-
ent (100%, 70%, and 50%) (IsolateTM, Irvine Scientific,Santa Ana, USA) and washed with HEPES-buffered cul-
ture medium (Gynemed, Lensahn, Germany).ICSI procedure
The micromanipulation procedure was performed on the
lid of a Petri dish (Nunc, Thermo Scientific, Roskilde,
Denmark) using droplets (20 μl) of HEPES-buffered cul-
ture medium (Gynemed, Lensahn, Germany), incubated at
37°C in 5% CO2 in air. To avoid evaporation, droplets
were covered with mineral oil (GM, Gynemed, Lensahn,
Germany). Prior to ICSI, a small amount of spermatozoa
(± 5 μl) was placed in a polyvinylpyrrolidone droplet
(GM PVP, Gynemed, Lensahn, Germany). Injection pip-
ettes (COOK Cook, Brisbane, Australia/Humagen Origio,
Malov, Denmark) and holding pipettes (COOK Cook,
Brisbane, Australia) were used for micromanipulation.
Micromanipulation (at 37°C on a heating plate) was per-
formed using an inverted microscope with modulation
contrast using a 200x magnification.Sperm immobilization and randomization
Randomization was performed at the time of oocyte
denudation. In case of an odd number of MII oocytes,
the last oocyte was randomized using a blinded envelope
system. Sibling MII oocytes were randomly assigned
to the STIm or TTIm technique. In the STIm group,
immobilization was performed by pressing the tail of the
spermatozoon to the bottom of the dish with the injection
pipette and then quickly withdrawing this pipette until a
clear bent in the middle of the flagellum was observed
[2,17,18] (see Figure 1). In the TTIm group the spermato-
zoon was immobilized three times: twice on the tail (STIm
technique applied twice) and once by compressing the
mid-piece [8,19] (see Figure 1). In case of not performing
the STIm or TTIm technique in a correct manner (further
kinetic movement of the sperm tail), another spermatozoa
Figure 1 Sperm immobilization. (a) Standard procedure STIm : pressing the tip of the tail against the lid of the dish with a microinjection
pipette until a clear small bend in the middle of the flagellum is visible (b) More aggressive procedure TTIm: based on application of the
standard procedure twice and compression of the sperm mid-piece once.
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tion in “either” groups.Fertilization control and embryo evaluation,
embryo transfer
After injection the oocytes were washed in droplets of
culture medium and placed into a new culture dish with
culture medium, divided into two groups (co-cultured)
and incubated overnight.
For both the STIm and TTIm group, fertilization con-
trol was performed 16 to 20 hours later on a stereo-
microscope on 37°C. Oocytes showing 2 pronuclei
(2PN) were identified as normally fertilized and were
cultured individually, the presence of 1 (PN) or 3 (3PN)
pronuclei was considered as abnormally fertilized.
On day 2 and day 3, embryo quality was assessed using
embryo development and morphology. The number and
size of blastomeres and the percentage of fragmentation
was evaluated. A good quality embryo (GQE) on day 2
was defined as a 4- cell stage embryos with less than
25% fragmentation and equally or slightly unequally
sized blastomeres and on day 3 (7-, 8-, or 9- cell stage
embryo with less than 25% fragmentation and equally or
slightly unequally sized blastomeres). On day 5 the blasto-
cyst stage was evaluated based on the presence of the
inner cell mass, the trophectoderm layer, the blastocoel
and the degree of expansion as described before [20]. A
blastocyst with a blastocoel completely filling the embryo,
a tightly packed inner cell mass and a trophectoderm with
many cells forming a cohesive epithelium was defined as a
good quality blastocyst at day 5.
A single (SET) or double (DET) embryo transfer was
performed, independent from the immobilization tech-
nique, on day 2 (N=47), day 3 (N=404) or day 5 (N=8)
according to the transfer policy decided by the gynaecolo-
gist (based on the Belgian law of July 2003) at the start of
the cycle and the number of fertilized oocytes on day 1.Clinical implantation and pregnancy results were
obtained for the STIm versus TTIm method and also for
mixed embryo transfers.Outcome variable and power calculation
This study was performed on sibling oocytes to test the
hypothesis that the fertilization rate (FR) per oocyte
would be higher in the TTIm group (70%) than in the
STIm group (65%) based on the average FR in our fertil-
ity centre during 2008.
The primary outcome variable was the FR, defined as
the number of normally fertilized oocytes over the total
number of MII oocytes and over the total number of
successfully injected MII oocytes. Therefore a total of
1528 mature oocytes were required in each group as-
suming a power of 0.80, α= 0.05, resulting in a total of
3056 MII oocytes in the whole study.
Secondary outcome variables included: number of
good quality embryos (GQE) on day 2 and day 3, utilisa-
tion rate (number of embryos available for embryo
transfer and cryopreservation over the total number of
normally fertilized oocytes) (UR), implantation rate per
embryo transferred (IR) [21] and implantation rate with
foetal heart beat per embryo transferred (FHB). Statis-
tical analyses were done using the Fisher Exact test with
a significance level of 0.05.Results
This randomised study, performed between April 2009
and January 2010 in 290 ICSI cycles, was done with a total
number of 3532 oocytes and after removal of the cumulus
cells, 3056 MII oocytes were available for ICSI. After ran-
domisation, 1528 MII oocytes (145 cycles) were assigned
to the STIm group and 1528 MII oocytes (138 cycles) to
the TTIm group. Oocytes (102MII) were excluded from
the analysis due to missing data on day 2 or day 1, if they
were excluded for analysis for day 2, than they were
Figure 2 Flow diagram of randomization of oocytes prior to ICSI.
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(STIm group) and 52 oocytes (TTIm group) were
excluded from the analysis (see Figure 2). Consequently,
1478 MII for the STIm group and 1476 MII for the
TTIm group were available for analysis. Mean age
(±SD) was 31.7 (±4.5) and 34.6 (±6.0) for female and
male partner respectively.
Both groups were comparable with respect to the
fertilization rate per injected MII oocyte (STIm: 67.1%
vs TTIm: 66.7%), fertilization rate per successfully
injected MII oocyte (STIm: 74.8% vs 75.8%), percentageTable 2 Results for embryological data
Total number of oocytes
Total number of matureoocytes = total number of injected oocytes
Outcome variable
% Fertilization rate/mature oocytes injected (n)
% Fertilization rate/successfully injected oocytes (n)
Parameter
% 1pn/mature oocytes injected (n)
% 3pn/mature oocytes injected (n)
N GQE d2/total n embryos on d2
N GQE d3/total n embryos on d3
N GQE d5/total n blastocysts on d5
% of good quality embryos on d2 (n)
% of good quality embryos on d3 (n)
% of good quality embryos on d5 (n)
% Utilisation rate (n)
“Parameters evaluated in both groups (STIm versus TTIm). The number of good qua
the other characteristics were equal in both groups.”of abnormally fertilized oocytes (STIm: 6.7% vs TTIm:
6.1%) and the embryo utilisation rate (STIm: 51.7% vs
TTIm: 47.2%) (UR) (Table 2). The number of good qual-
ity embryos on day 3 was significantly higher in the STIm
group compared to the TTIm group (STIm: 37.5% vs
TTIm: 32.2%; p 0.02). The embryo quality on day 2
(STIm: 33.0% vs TTIm: 31.8%) and day 5 (STIm: 17.2% vs
TTIm: 20.7%) was comparable in both groups, although
only a small number of day 5 blastocysts were included
(Table 2). The pregnancy outcome as measured by IR per
embryo transferred (STIm: 31.0% vs TTIm: 23.9%) and IR3532
3056
STIm -group TTIm-group P-value
67.1 (992/1478) 66.7 (984/1476) 0.81
74.8 (992/1326) 75.8 (984/1298) 0.56
4.5 (67/1478) 3.5 (51/1476) 0.16




33.0 (326) 31.8 (312) 0.56
37.5 (348) 32.2 (300) 0.0172
17.2 (5) 20.7 (6) >0.9999
51.7 (513) 47.2 (464) 0.24
lity embryos on day 3 was significantly different between both groups;
Table 3 Results for clinical data
Parameter STIm -group TTIm-group P-value
N embryos transferred 145 138
% Implantation/embryo transferred (n) 31.0 (45/145) 23.9 (33/138) ns
% Implantation with featal heart beat (FHB)/embryo transferred (n) 27.6 (40/145) 23.2 (32/138) ns
N embryos transferred in SET 63/145 63/138
N embryos transferred in cycli with at least 2 embryos transferred 82/145 75/138
Statistical analysis was performed using Fisher’s exact test.
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27.6% vs TTIm: 23.2%) was comparable in the STIm
group and the TTIm group (see Table 3).Discussion
In this RCT, the hypothesis that the post-ICSI FR would
be higher after TTIm than after STIm was not con-
firmed. Furthermore, the proportion of good quality
embryos on day 3 (secondary outcome variable) was sig-
nificantly lower in the TTIm group than in the STIm
group. Collectively, these data suggest that more ‘aggres-
sive’ TTIm technique has no advantages compared to
the STIm technique before ICSI. To the best of our
knowledge, our study represents the first randomized
study in a large patient population, with FR as primary
outcome variable, based on a priori power calculation and
a sufficiently high number (n= 2954) sibling MII oocytes
available for analysis.
The results of our study confirm the data (similar FR
and embryo quality on day 2) from another RCT [8], but
including only 205 MII oocytes to compare 3 different
immobilization techniques: compressing the mid-piece
(comparable to the TTIm technique used in our study),
cutting the tail at the mid-portion and dissecting the tail
of the spermatozoon at the tip. However, the results of
our study are in disagreement with the increased FR
after ICSI reported in non-randomized retrospective
case control studies [1,2,4,7] using other mechanical, ag-
gressive sperm immobilization techniques in different
types of spermatozoa (immotile, thawed, epididymal),
when compared to the standard immobilization method.
Furthermore, when compared to STIm, we did not con-
firm improved outcome after TTIm for previously
reported secondary outcome variables like: a significant
decline in degenerated oocytes [7] or a decrease of the
number of 1PN oocytes [1].
The results of our study don’t allow us to draw con-
clusions on the underlying mechanisms. A possible con-
sideration could be that the amount of damage needed
to immobilize a motile spermatozoa is not depending on
the number of strokes (STIm vs TTIm) but rather on
the region (mid-piece) where we immobilized the sperm
tail. We have to keep in mind that other reactions suchas hyperactivity due to the mitochondria at the site of
fertilization might have an influence on the fertilization rate
[13]. In addition, we cannot exclude, based on our results,
that no additional damage occurs to the centrosomes of the
spermatozoa after both immobilization techniques. The
importance of centrosomes has been studied in the last few
years, however the exact comprehension of the mechan-
isms remains unclear [22].Conclusions
In conclusion, this randomized trial showed that, when
compared to STIm, TTIm did not result in a higher
post-ICSI fertilization rate (primary outcome) and was
associated with a lower number of good quality embryos
on day 3 and with similar pregnancy rates (secondary
outcomes), suggesting that the more ‘aggressive’ TTIm
technique has no advantages compared to the STIm
technique before ICSI.
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